Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review

Clinical Nutrition

Volumn 37, Issue 1, 2018, Pages 123-129

  Zhan, Yong le ^a   Zhan, Yong an ^b   Dai, Shi xue ^c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

FODMAP diet; Gastrointestinal symptoms; IBD; Meta analysis

Indexed keywords

ABDOMINAL PAIN; ARTICLE; BLOATING; CLINICAL EFFECTIVENESS; CONSTIPATION; DIARRHEA; DIET THERAPY; FATIGUE; FERMENTABLE OLIGOSACCHARIDE DISACCHARIDE MONOSACCHARIDE AND POLYOL DIET; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; NAUSEA; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 85020130789     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2017.05.019     Document Type: Article

References (52)

1. Raghu Subramanian, C., Triadafilopoulos, G., Care of inflammatory bowel disease patients in remission. Gastroenterol Rep (Oxf) 4:4 (2016), 261–271.
2. Molodecky, N.A., Soon, I.S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:1 (2012), 46–54 e42 quiz e30.
3. Wehkamp, J., Gotz, M., Herrlinger, K., Steurer, W., Stange, E.F., Inflammatory bowel disease. Dtsch Arztebl Int 113:5 (2016), 72–82.
4. Ruemmele, F.M., Role of diet in inflammatory bowel disease. Ann Nutr Metab 68:Suppl. 1 (2016), 33–41.
5. Carter, M.J., Lobo, A.J., Travis, S.P., Ibd Section BSoG. Guidelines for the management of inflammatory bowel disease in adults. Gut 53:Suppl. 5 (2004), V1–V16.
6. Durchschein, F., Petritsch, W., Hammer, H.F., Diet therapy for inflammatory bowel diseases: the established and the new. World J Gastroenterol 22:7 (2016), 2179–2194.
7. Charlebois, A., Rosenfeld, G., Bressler, B., The impact of dietary interventions on the symptoms of inflammatory bowel disease: a systematic review. Crit Rev Food Sci Nutr 56:8 (2016), 1370–1378.
8. Halpin, S.J., Ford, A.C., Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 107:10 (2012), 1474–1482.
9. Staudacher, H.M., Lomer, M.C.E., Anderson, J.L., Irving, P.M., Whelan, K., Impact of a diet low in fermentable carbohydrates on gastrointestinal symptoms, stool output and faecal pH in patients with irritable bowel syndrome: a randomised controlled trial. Proc Nutr Soc, 70(70), 2011.
10. Stein, D., Ansari, I., Cahill, J., Agrawal, D., Naik, A.S., Zadvornova, Y., Tu1261 the majority of inflammatory bowel disease patients feel that an elimination diet trial had resulted in disease symptom improvement. Gastroenterology, 148(4), 2015 S-840-S-1.
11. Marsh, A., Eslick, E.M., Eslick, G.D., Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 55:3 (2016), 897–906.
12. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 4, 2015, 1.
13. Francis, C.Y., Morris, J., Whorwell, P.J., The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 11:2 (1997), 395–402.
14. Svedlund, J., Sjodin, I., Dotevall, G., GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:2 (1988), 129–134.
15. Higgins, J.P.T., Altman, D.G., Chapter 8: assessing risk of bias in included studies. Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions, 2008, John Wiley & Sons, Chichester (UK).
16. Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., Chipponi, J., Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:9 (2003), 712–716.
17. Hozo, S.P., Djulbegovic, B., Hozo, I., Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol, 5, 2005, 13.
18. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
19. Croagh, C., Shepherd, S.J., Berryman, M., Muir, J.G., Gibson, P.R., Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 13:12 (2007), 1522–1528.
20. Gearry, R.B., Irving, P.M., Barrett, J.S., Nathan, D.M., Shepherd, S.J., Gibson, P.R., Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 3:1 (2009), 8–14.
21. Pedersen, N., EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS. Dan Med J, 62(12), 2015, B5168.
22. Halmos, E.P., Christophersen, C.T., Bird, A.R., Shepherd, S.J., Muir, J.G., Gibson, P.R., Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn's disease: a randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol, 7, 2016, e164.
23. Maagaard, L., Ankersen, D.V., Vegh, Z., Burisch, J., Jensen, L., Pedersen, N., et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 22:15 (2016), 4009–4019.
24. Prince, A.C., Myers, C.E., Joyce, T., Irving, P., Lomer, M., Whelan, K., Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis 22:5 (2016), 1129–1136.
25. Barrett, J.S., Gibson, P.R., Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?., 5(4), 2012, 261–268.
26. Halmos, E.P., Power, V.A., Shepherd, S.J., Gibson, P.R., Muir, J.G., A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146:1 (2014), 67–75 e5.
27. Wilder-Smith, C.H., Materna, A., Wermelinger, C., Schuler, J., Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther 37:11 (2013), 1074–1083.
28. Yao, C.K., Tan, H.L., van Langenberg, D.R., Barrett, J.S., Rose, R., Liels, K., et al. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet 27:Suppl 2 (2014), 263–275.
29. Marcason, W., What is the FODMAP diet?. J Acad Nutr Diet, 112(10), 2012, 1696.
30. Barrett, J.S., Irving, P.M., Shepherd, S.J., Muir, J.G., Gibson, P.R., Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 30:2 (2009), 165–174.
31. Wiecek, S., Wos, H., Radziewicz, W.I., Komraus, M., Grzybowska, C.U., Disaccharidase activity in children with inflammatory bowel disease. Turk J Gastroenterol Off J Turk Soc Gastroenterol 25:2 (2014), 185–191.
32. Gibson, P.R., Shepherd, S.J., Personal view: food for thought – western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther 21:12 (2005), 1399–1409.
33. Murray, K., Wilkinson-Smith, V., Hoad, C., Costigan, C., Cox, E., Lam, C., et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 109:1 (2014), 110–119.
34. Barrett, J.S., Gearry, R.B., Muir, J.G., Irving, P.M., Rose, R., Rosella, O., et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 31:8 (2010), 874–882.
35. Marciani, L., Cox, E.F., Hoad, C.L., Pritchard, S., Totman, J.J., Foley, S., et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology, 138(2), 2010 469–77, 77 e1.
36. Xu, L., Yu, W., Jiang, J., Li, N., Clinical benefits after soluble dietary fiber supplementation: a randomized clinical trial in adults with slow-transit constipation. Zhonghua Yi Xue Za Zhi 94:48 (2014), 3813–3816.
37. Yang, J., Wang, H.P., Zhou, L., Xu, C.F., Effect of dietary fiber on constipation: a meta analysis. World J Gastroenterol 18:48 (2012), 7378–7383.
38. Murakami, K., Sasaki, S., Okubo, H., Takahashi, Y., Hosoi, Y., Itabashi, M., et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr 61:5 (2007), 616–622.
39. Hou, J.K., Lee, D., Lewis, J., Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 12:10 (2014), 1592–1600.
40. Eswaran, S., Muir, J., Chey, W.D., Fiber and functional gastrointestinal disorders. Am J Gastroenterol 108:5 (2013), 718–727.
41. Markland, A.D., Palsson, O., Goode, P.S., Burgio, K.L., Busby-Whitehead, J., Whitehead, W.E., Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 108:5 (2013), 796–803.
42. Pedersen, N., Vinding, K.K., Vegh, Z., Casén, C., Ankersen, D.V., Carlsen, K., et al. Sa1245 gut microbiota in IBD patients with IBS before and after 6 weeks of low FODMAP diet. Gastroenterology, 146(5), 2014, S-241.
43. Halmos, E.P., Christophersen, C.T., Bird, A.R., Shepherd, S.J., Gibson, P.R., Muir, J.G., Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 64:1 (2015), 93–100.
44. Hopkins, M.J., Cummings, J.H., Macfarlane, G.T., Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J Appl Microbiol 85:2 (1998), 381–386.
45. Smith, P.A., The tantalizing links between gut microbes and the brain. Nature 526:7573 (2015), 312–314.
46. Bravo, J.A., Julio-Pieper, M., Forsythe, P., Kunze, W., Dinan, T.G., Bienenstock, J., et al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol 12:6 (2012), 667–672.
47. Bonaz, B.L., Bernstein, C.N., Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144:1 (2013), 36–49.
48. Scaldaferri, F., Pizzoferrato, M., Lopetuso, L.R., Musca, T., Ingravalle, F., Sicignano, L.L., et al. Nutrition and IBD: malnutrition and/or Sarcopenia? A practical guide. Gastroenterol Res Pract, 2017, 2017, 8646495.
49. Donnellan, C.F., Yann, L.H., Lal, S., Nutritional management of Crohn's disease. Ther Adv Gastroenterol 6:3 (2013), 231–242.
50. Does a low FODMAP diet help IBS?. Drug Ther Bull 53:8 (2015), 93–96.
51. Elia, M., The ‘MUST’ report. Nutritional screening for adults: a multidisciplinary responsibility. Development and use of the ‘Malnutrition Universal Screening Tool’ (MUST) for adults., 2003, British Association for Parenteral and Enteral Nutrition (BAPEN).
52. Azpiroz, F., Guyonnet, D., Donazzolo, Y., Gendre, D., Tanguy, J., Guarner, F., Digestive symptoms in healthy people and subjects with irritable bowel syndrome: validation of symptom frequency questionnaire. J Clin Gastroenterol 49:7 (2015), e64–70.